Controls would take away the industry's incentive to develop new lifesaving medications and therapies.

Drug prices have recently become less expensive with the spread of generic versions, but Medicaid support seems to make drugs more expensive.

At a time when cancer, Alzheimer's, and other vicious diseases would benefit most from technological advances, a new law may attempt to stifle innovation.

A public health care plan would have certain advantages. That's precisely the problem.

There are good reasons for the European Union to worry about the health of its pharmaceutical firms, but fortunately there are things it can improve.

Left ventricular assist devices, or "heart pumps," are proving to be the best available option for patients with advanced heart failure, and the technology has huge potential for improvement.